Subscribe To
CASI / CASI Pharma (CASI) Sees Hammer Chart Pattern: Time to Buy?
CASI News
By Market Watch
January 6, 2023
Casi Pharmaceuticals to run clinical trial for multiple myeloma drug in China
Shares of Casi Pharmaceuticals Inc. CASI, +3.63% were up 10% in premarket trading on Friday after the company said China will allow a Phase 1 clinical more_horizontal
By PRNewsWire
August 5, 2022
CASI PHARMACEUTICALS TO REPORT SECOND QUARTER 2022 FINANCIAL RESULTS AND HOST CONFERENCE CALL AUGUST 12, 2022
ROCKVILLE, Md. and BEIJING , Aug. 5, 2022 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on devel more_horizontal
By Market Watch
June 2, 2022
CASI Pharmaceuticals stock falls after reverse split takes effect
Shares of CASI Pharmaceuticals Inc. CASI, +18.01% are actually falling in premarket trading Thursday, as a 1-for-10 reverse stock split took effect. W more_horizontal
By Seeking Alpha
May 12, 2022
CASI Pharmaceuticals, Inc.'s (CASI) CEO Wei-Wu He on Q1 2022 Results - Earnings Call Transcript
CASI Pharmaceuticals, Inc. (NASDAQ:CASI ) Q1 2022 Earnings Conference Call May 12, 2022 8:00 AM ET Company Participants Wei-Wu He - Chairman and Chief more_horizontal
By Zacks Investment Research
May 12, 2022
CASI Pharmaceuticals, Inc. (CASI) Reports Q1 Loss, Misses Revenue Estimates
CASI Pharmaceuticals, Inc. (CASI) delivered earnings and revenue surprises of 40% and 0.96%, respectively, for the quarter ended March 2022. Do the nu more_horizontal
By Seeking Alpha
March 28, 2022
CASI Pharmaceuticals, Inc. (CASI) CEO Wei-Wu He on Q4 2021 Results - Earnings Call Transcript
CASI Pharmaceuticals, Inc. (CASI) CEO Wei-Wu He on Q4 2021 Results - Earnings Call Transcript more_horizontal
By Zacks Investment Research
October 6, 2021
CASI Pharma (CASI) Sees Hammer Chart Pattern: Time to Buy?
CASI Pharma (CASI) has been struggling lately, but the selling pressure may be coming to an end soon. more_horizontal
By Zacks Investment Research
October 6, 2021
CASI Pharma (CASI) Sees Hammer Chart Pattern: Time to Buy?
CASI Pharma (CASI) has been struggling lately, but the selling pressure may be coming to an end soon. more_horizontal